Innovative Clinical Solutions,
Ltd. (ICSN) announced an agreement to
merge Clinical Studies, Ltd. (CSL), its clinical studies and healthcare
research subsidiary, with a subsidiary of Comprehensive NeuroScience, Inc., a
privately held clinical knowledge company focused on the development,
evaluation and appropriate use of drugs used to treat neuropsychiatric
illnesses.
The combined business will provide multi-therapeutic, Phase I-IV clinical
research services as well as an array of medical information technology
services to the pharmaceutical and biotechnology industries.
Seifert Systems Invests in Energy Efficiency to Strengthen Operations
For manufacturers, energy is more than just another operating expense. It plays a critical role…
Learn More
Innovative
Clinical Solutions, Ltd. (ICSL) will remain an independent, public company
with substantial stock ownership in Comprehensive NeuroScience, Inc., which
will remain a private company.
